Претраживање
Приказ резултата 1-10 од 91
Influence of microenvironmental conditions on hybridoma cell growth inside the alginate-poly-L-lysine microcapsule
(Elsevier Sci Ltd, Oxford, 2007)
A mathematical model was formulated to describe hybridoma cell growth within the alginate-poly-L-lysine (alginate-PLL) microcapsules during air-lift bioreactor cultivation. Model development was based on experimentally ...
EURRECA-Estimating Selenium Requirements for Deriving Dietary Reference Values
(Taylor & Francis Inc, Philadelphia, 2013)
Current reference values for selenium, an essential micronutrient, are based on the intake of selenium that is required to achieve maximal glutathione peroxidase activity in plasma or erythrocytes. In order to assess the ...
Expression analysis of jak-stat dependent s100 calcium binding proteins a4 and a12 in myeloproliferative neoplasms
(Ferrata Storti Foundation, Pavia, 2013)
Serologic rebounds after one-year-long treatment for congenital toxoplasmosis
(Lippincott Williams & Wilkins, Philadelphia, 2000)
Transcriptional profiling of human erythroid progenitors from g-csf mobilized and nonmobilized peripheral blood
(Ferrata Storti Foundation, Pavia, 2013)
Addition of the degree of bone marrow fibrosis to IPSS in new scoring system improve prediction of survival in primary myelofibrosis
(Ferrata Storti Foundation, Pavia, 2013)
Oxidative stress in myeloproliferative neoplasms
(Ferrata Storti Foundation, Pavia, 2014)
Globin genes induction by nitric oxide of stromal cell origin
(Amer Soc Hematology, Washington, 2007)
Imageability ratings across languages
(Springer, New York, 2018)
Imageability is a psycholinguistic variable that indicates how well a word gives rise to a mental image or sensory experience. Imageability ratings are used extensively in psycholinguistic, neuropsychological, and ...
Hydroxyurea induces the eNOS-cGMP pathway in endothelial cells
(Amer Soc Hematology, Washington, 2006)
Hydroxyurea is a cell-cycle-specific drug that has been used to treat myeloproliferative diseases and sickle cell anemia. We have recently shown that hydroxyurea, like nitric oxide (NO)-donor compounds, increased cGMP ...